HMGB1’s extracellular inflammatory activity in sepsis was first identified in 1999 by administering the bacterial endotoxin (lipopolysaccharide, LPS) in vitro and in vivo models (Wang et al., 1999). This evidence concerns the gene HMGB1 and Sepsis.